Log In
Print
BCIQ
Print
Print this Print this
 

Nanoformulated indomethacin, submicron indomethacin (IP 940)

  Manage Alerts
Collapse Summary General Information
Company Iroko Pharmaceuticals LLC
DescriptionNanoformulation of the NSAID indomethacin using SoluMatrix nanoformulation technology
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationPain
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today